A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

NCT02723994 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Ruxolitinib
DRUG: Asparaginase Erwinia Chrysanthemi
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Leucovorin Calcium
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Thioguanine
DRUG: Vincristine Sulfate

Sponsor

Incyte Corporation

Collaborators

[object Object]